Globus Medical (GMED) Net Cash Flow Growth (3y) (2014 - 2026)
Globus Medical (GMED) Net Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn | -48.90% |
| 10 | Globus Medical | 10.61 Bn | 9.98 Bn | 525.79 Mn | -17.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.41% |
| Dec 31, 2025 | 106.47% |
| Sep 30, 2025 | 117.77% |
| Jun 30, 2025 | -46.22% |
| Mar 31, 2025 | -121.50% |
| Dec 31, 2024 | 43.98% |
| Sep 30, 2024 | 30.81% |
| Jun 30, 2024 | -14.44% |
| Mar 31, 2024 | -26.75% |
| Dec 31, 2023 | 162.44% |
| Sep 30, 2023 | -32.80% |
| Jun 30, 2023 | 332.19% |
| Mar 31, 2023 | 62.88% |
| Dec 31, 2022 | -16.61% |
| Sep 30, 2022 | -32.93% |
| Jun 30, 2022 | -85.13% |
| Mar 31, 2022 | 79.53% |
| Sep 30, 2021 | 66.98% |
| Jun 30, 2021 | 317.97% |
| Mar 31, 2021 | -940.53% |